Comparison of natural course, intravitreal triamcinolone, and intravitreal bevacizumab for treatment of macular edema secondary to branch retinal vein occlusion

Journal of Ocular Pharmacology and Therapeutics

Volumn 29, Issue 1, 2013, Pages 5-9

  Kwon, Soon Il ^a   Kim, Young Wook ^a   Bang, Ye Won ^a   Lee, Joo Yeon ^a   Park, In Won ^a  

^a Hallym University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE;

ADULT; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL MACULAR THICKNESS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RETINA MACULA EDEMA; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULA LUTEA; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE; VISUAL ACUITY;

EID: 84872846589     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2011.0249     Document Type: Article

References (23)

1. Ennema, M.C., and Zeeman, W.P. Venous occlusions in the retina. Ophthalmologica. 126:329-347, 1953
2. Klein, R., Klein, B.E., Moss, S.E., and Meuer, S.M. The epidemiology of retinal vein occlusion: The Beaver Dam Eye Study. Trans. Am. Ophthalmol. Soc. 98:133-141, 2000
3. Mitchell, P., Smith, W., and Chang, A. Prevalence and associations of retinal vein occlusion in Australia: The Blue Mountains Eye Study. Arch. Ophthalmol. 114:1243-1247, 1996
4. Klein, R., Moss, S.E., Meuer, S.M., and Klein, B.E. The 15-year cumulative incidence of retinal vein occlusion: The Beaver Dam Eye Study. Arch. Ophthalmol. 126:513-518, 2008
5. Gutman, F.A., Zegarra, H., and Zakov, Z.N. The natural course of temporal retinal vein occlusion. Trans. Am. Acad. Ophthalmol. Otolaryngol. 78:178-192, 1974
6. Hayreh, S.S., Rojas, P., Podhajsky, P., Montague, P., and Woolson, R.F. Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology. 90:488-506, 1983
7. Magargal, L.E., Kimmel, A.S., Sanborn, G.E., and Annesley, W.H., Jr. Temporal branch retinal vein obstruction: A review. Ophthal. Surg. 17:240-246, 1986
8. Michels, R.G., and Gass, J.D. The natural course of retinal branch vein obstruction. Trans. Am. Acad. Ophthalmol. Otolaryngol. 78:166-177, 1974
9. Roseman, R.L., and Olk, R.J. Krypton red laser photocoagulation for branch retinal vein occlusion. Ophthalmology. 94:1120-1125, 1987
10. Argon laser phtocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am. J. Ophthalmol. 98:271-282, 1984
11. Cekic, O., Chang, S., Tseng, J.J., Barile, G.R., DelPriore, L.V., Weissman, H., et al. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina. 25:851-855, 2005
12. Krepler, K., Ergun, E., Sacu, S., Richter-Muksch, S., Wagner, J., Stur, M., et al. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: A pilot study. Acta. Ophthalmol. Scand. 83:600-604, 2005
13. Chen, S.D., Sundaram, V., Lochhead, J., and Patel, C.K. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion. Am. J. Ophthalmol. 141:876-883, 2006
14. Rabena, M.D., Pieramici, D.J., Castellarin, A.A., Nasir, M.A., and Avery, R.L. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina. 27: 419-425, 2007
15. Gü ndü z, K., and Bakri, S.J. Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion. Eye. 22:1168-1171, 2008
16. Campochiaro, P.A., Hafiz, G., Shah, S.M., Nquyen, Q.D., Ying, H., Do, D.V., et al. Ranibizumab for macular edema due to retinal vein occlusions: Implication of VEGF as a critical stimulator. Mol. Ther. 16:791-799, 2008
17. Campochiaro, P.A., Heier, J.S., Feiner, L., Gray, S., Rundle, A.C., Murahashi, W.Y., et al. Ranibizumab for macular edema following branch retinal vein occlusion: Six-month primary end point results of a phase III study. Ophthalmology. 117:1102-1112, 2010
18. Patel, P.J., Zaheer, I., and Karia, N. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion. Eye. 22:60-64, 2008
19. Byun, Y.J., Roh, M.I., Lee, S.C., and Koh, H.J. Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal occlusion. Graefes. Arch. Clin. Exp. Ophthalmol. 248:963-971, 2010
20. Stefanson, E. Treatment of branch retinal vein occlusion. Acta. Ophthalmol. 86:122-123, 2008
21. Scott, I.U., Ip, M.S., Vanveldhuisen, P.C., Oden, N.L., Blodi, B.A., Ficher, M., et al. A randomized trial comparing the efficacy and safty of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch. Ophthalmol. 127:1115-1128, 2009
22. Haller, J.A., Bandello, F., Belfort, R. Jr., Blumenkranz, M.S., Gillies, M., Heier, J., et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 117:1134-1146, 2010
23. Shroff, D., Mehta, D.K., Arora, R., Narula, R., and Chauhan, D. Natural history of macular status in recent-onset branch retinal vein occlusion: An optical coherence tomography study. Int. Ophthalmol. 28:261-268, 2008